https://www.selleckchem.com/pr....oducts/mptp-hydrochl
Parkinson disease (PD) is a common neurodegenerative disease. A treatment that prevents or delays development of PD is a critical unmet need. Terazosin and closely related drugs were recently discovered to enhance glycolysis and reduce PD progression in animal models and human clinical databases. To determine whether use of terazosin, doxazosin, and alfuzosin is associated with a decreased risk of developing PD. This cohort study used active comparator control and propensity score-matched data from Danish nationwide health re
Curtir
Comentario
Compartilhar
